ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,938Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 1300

$385K Total Retail Price of All Prescriptions

Rank: 77 out of 1300

430 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 430 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

14% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LISINOPRIL 467 372 1 2
LEVOTHYROXINE SODIUM 312 273 2 1
METFORMIN HCL 278 211 3 7
SIMVASTATIN 258 210 4 3
GLIPIZIDE 217 202 5 33
OMEPRAZOLE 209 192 6 4
HYDROCODONE-ACETAMINOPHEN 200 176 S3 7 5
AMLODIPINE BESYLATE 199 194 8 6
PRAVASTATIN SODIUM 196 189 9 23
METOPROLOL TARTRATE 185 166 10 11
ATENOLOL 176 139 11 12
FUROSEMIDE 166 153 12 8
LOVASTATIN 148 144 13 22
TRAMADOL HCL 138 135 14 17
LANTUS 134 111 15 43
WARFARIN SODIUM 130 128 16 9
ATORVASTATIN CALCIUM 125 88 17 13
POTASSIUM CHLORIDE 96 91 18 18
GABAPENTIN 85 79 19 15
ALLOPURINOL 82 77 20 29
ZOLPIDEM TARTRATE 81 80 21 14
RANITIDINE HCL 77 60 22 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 64 23 21
GLYBURIDE 70 47 R 24 76
ADVAIR DISKUS 68 68 25 41
FAMOTIDINE 66 45 26 73
HYDROCHLOROTHIAZIDE 66 62 26 10
BUMETANIDE 63 61 28 148
METOPROLOL SUCCINATE 63 61 28 24
DONEPEZIL HCL 62 62 30 32
TAMSULOSIN HCL 62 62 30 25
CITALOPRAM HBR 59 46 32 19
PANTOPRAZOLE SODIUM 57 52 33 36
ACTOS 56 47 34 121
MIRTAZAPINE 55 55 35 50
NAMENDA 52 41 36 51
TRIAMTERENE-HCTZ 51 50 37 54
PROAIR HFA 51 51 37 42
ISOSORBIDE MONONITRATE ER 50 50 39 82
KLOR-CON M20 50 47 39 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.